Authors:
Fukaya, KI
Asahi, S
Nagamori, S
Sakaguchi, M
Gao, C
Miyazaki, M
Namba, M
Citation: Ki. Fukaya et al., Establishment of a human hepatocyte line (OUMS-29) having CYP 1A1 and 1A2 activities from fetal liver tissue by transfection of SV-10 LT, IN VITRO-AN, 37(5), 2001, pp. 266-269
Authors:
Yoshitomi, S
Ikemoto, K
Takahashi, J
Miki, H
Namba, M
Asahi, S
Citation: S. Yoshitomi et al., Establishment of the transformants expressing human cytochrome P450 subtypes in HepG2, and their applications on drug metabolism and toxicology, TOX VITRO, 15(3), 2001, pp. 245-256
Authors:
Okumura, T
Takeuchi, S
Motomura, W
Yamada, H
Egashira, S
Asahi, S
Kanatani, A
Ihara, M
Kohgo, Y
Citation: T. Okumura et al., Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation, BIOC BIOP R, 280(4), 2001, pp. 976-981
Authors:
Komatsu, T
Yamazaki, H
Asahi, S
Gillam, EMJ
Guengerich, FP
Nakajima, M
Yokoi, T
Citation: T. Komatsu et al., Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: Roles of cytochromes P4502C9, 2C19, and 3A4, DRUG META D, 28(11), 2000, pp. 1361-1368
Authors:
Ohmori, T
Asahi, S
Sato, C
Maki, F
Masumoto, A
Okada, K
Citation: T. Ohmori et al., Bcl-2 protein expression and gut neurohormonal polypeptide/amine production in colorectal carcinomas and tumor-neighboring mucosa, which closely correlate to the occurrence of tumor, HIST HISTOP, 14(1), 1999, pp. 37-44
Authors:
Yamazaki, H
Nakajima, M
Nakamura, M
Asahi, S
Shimada, N
Gillam, EMJ
Guengerich, FP
Shimada, T
Yokoi, T
Citation: H. Yamazaki et al., Enhancement of cytochrome P-450 3A4 catalytic activities by cytochrome b(5) in bacterial membranes, DRUG META D, 27(9), 1999, pp. 999-1004